No Detail Found!

Five-year experience of second-generation cryoballoon ablation for paroxysmal atrial fibrillation from a tertiary cardiac care center of pakistan: a retrospective chart review

Author(s)
Muhammad Sarim Ansari National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Ghazala Irfan National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Zubair Mumtaz National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Faisal Qadir National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Maqsood Alam National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Sajid Ali Shaikh National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Abdul Mueed National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Abstract
Objectives: The study aimed at assessing the outcome of pulmonary vein isolation (PVI) using second-generation cryoballoon, Arctic Front Advance, Medtronic (CB -Adv) as a rhythm control strategy for drug-resistant paroxysmal atrial fibrillation (PAF) in a cardiac tertiary care center of Pakistan. Methodology: Fifty patients had PVI with CB-Adv for symptomatic drug-resistant PAF at the National Institute of Cardiovascular Diseases, Karachi, Pakistan, during 2017 -2022. Patients were followed-up in the clinic on the 1st, 3rd, and 6th month after the ablation. Twenty -four hours of Holter monitoring of electrocardiogram was obtained on each visit. We conducted a retrospective chart review after approval from the ethical review committee. We collected all the patients' demographic and clinical data, procedural results, and reports of Holter monitoring. The primary outcome was successful PVI and freedom from atrial tachyarrhythmia (Ata) on a 6-month follow-up. Results: We enrolled all 50 patients (34 male, 68%; mean age 55.14 ± 7.94 years) treated with PVI using CB-Adv. The mean duration of symptoms was 30.28 ± 13.48 months. PVI with CBAdv was found to be curative in 49 patients (98%). Following the procedure, pericardial effusion was found in one patient (2%), whereas one patient (2%) had a retroperitoneal hematoma. On a six-month follow-up, only one patient (2%) had a recurrence of Ata, which was PAF. Conclusion: Our experience of PVI with CB-Adv has shown a high success rate of the procedure for rhythm control in patients who have PAF, which is resistant to antiarrhythmic drugs (AADs).
Publication Details
Page(s) 146-151
Published Journal: Pakistan Heart Journal, Volume: 56, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
paroxysmal atrial fibrillation, Pulmonary vein isolation, cryoballoon ablation, second -generation cryoballoon, atrial tachyarrhythmia
0

Citations

0

Downloads

51

Views